Daniel et al. (1991) Schizophrenia Study

Daniel et al. (1991) study tested what a dopamine-related drug does to the brain in schizophrenia. Ten patients did a card-sorting test on two days, once after amphetamine and once after a placebo, while a scanner measured blood flow. On amphetamine, the front of the brain became more active, which fits the idea that these patients have too little dopamine there.

Key Takeaways

Aim

  • To test whether amphetamine, a drug that makes the brain release dopamine (a brain chemical), raises activity in the prefrontal cortex (the front of the brain).
  • The patients had schizophrenia, a serious mental illness.

Method

  • A laboratory experiment (a controlled test in an artificial setting) on ten patients with chronic (long-lasting) schizophrenia. All were stable on haloperidol, an antipsychotic drug.
  • It was double-blind (neither patients nor raters knew which pill was given) and placebo-controlled (a dummy pill was the comparison).
  • Each patient had both conditions on two days. This is repeated measures. The order was counterbalanced (varied between patients).
  • About 120 minutes after the pill (amphetamine or placebo), a scanner measured blood flow. Patients did two tasks: a card-sorting test, and a simple control task to compare it with.
  • The independent variable was the pill. The dependent variable was blood flow in brain regions. More blood flow means a more active region.

Results

  • Amphetamine lowered overall blood flow only slightly.
  • On the placebo, blood flow did not clearly rise during the card sort, compared with the control task.
  • On amphetamine, activity rose clearly in the left dorsolateral prefrontal cortex (the upper side of the front of the brain). Activity elsewhere in the left cortex (the outer layer) was held down.
  • Patients also got more card sorts right on amphetamine (84 against 72). That is a performance result, not a brain finding.

Conclusion

  • Amphetamine seems to help the cortex focus its activity on a task, which fits a link between dopamine and low frontal activity in schizophrenia.
  • The authors call this tentative because the sample was small and amphetamine is not specific to dopamine.

Strengths

  • Control: the study was double-blind and placebo-controlled, so expectations were less likely to change the results. (A placebo is a dummy pill.)
  • Repeated measures: each patient was their own comparison, so differences between people did not explain the drug effect.
  • Objective measure: blood flow in a scan is a physical measurement, so it avoids social desirability (answering to look good) and demand characteristics.
  • Standardisation: dose, timing, head position and tasks were the same each time, so the study could be repeated.

Limitations

  • Sample size: only ten patients, so one region’s result could depend on a few people. The authors themselves call the conclusions tentative.
  • Population bias: all ten were chronic inpatients from one US hospital, mostly white, on haloperidol, so the findings may not apply to other people with schizophrenia.
  • Construct validity: only one cognitive test measured prefrontal function. (Construct validity means measuring what the study claims to measure.)
  • Ecological validity: lying in a scanner sorting cards is not like everyday life.
  • Amphetamine affects several brain chemicals, so the study cannot show that dopamine caused the effect.
  • Reductionism: explaining schizophrenia by activity in one brain region leaves out upbringing and life events.

Ethical Issues

  • Informed consent: the patients were seriously ill, so it may be hard to know how well they understood. Way of dealing with it: ask a review board to approve the study, as happened here.
  • Protection from harm: amphetamine can make psychosis (losing touch with reality) worse. Way of dealing with it: keep patients on haloperidol and monitor them. One patient still got worse.
  • Scanning for research: patients breathed a radioactive tracer with no treatment benefit. Way of dealing with it: have a radiation safety committee approve the study.
  • Right to withdraw and debrief: the paper does not report either. Way of dealing with it: tell patients they can stop, and explain the study afterwards.

Exam Use

  • Some questions ask only for brain findings (neuropsychology). Give the brain findings first; OCR’s report says few candidates kept to neuropsychology.
  • Say “prefrontal cortex”, not just “cortex” or “brain”.
  • This study is about too little dopamine in the front of the brain. Do not write that it showed too much dopamine causes schizophrenia.
  • The 13-mark question is the longest on the paper: you give a judgement and use two studies. This study can be evidence in an answer on biological explanations.
Simply Psychology Answers
Instant answers built on 19+ years of trusted expertise.

Background

Schizophrenia is a serious mental illness that affects how a person thinks, feels and behaves. Some brain studies of people with it had found low activity in the front of the brain, the prefrontal cortex. This is called hypofrontality. It showed up most during tasks that need that area.

Dopamine is a brain chemical. It carries messages between nerve cells, and the next cell has receptors (parts that receive the message). The researchers reasoned that low dopamine activity in the cortex might partly cause the low activity.

Simply Psychology Answers
Instant answers built on 19+ years of trusted expertise.

Amphetamine makes the brain release dopamine. So it can test the idea. It should raise activity during a prefrontal task.

Simply Psychology Answers
Instant answers built on 19+ years of trusted expertise.

OCR’s dopamine hypothesis says that schizophrenia is linked to too much dopamine in some brain areas. Dopamine nerve cells fire too often, so more dopamine reaches receptors. OCR also says the frontal lobe is less active during tasks such as the Wisconsin Card Sort Test.

These two ideas can seem to clash.

A simple picture has two parts: too much dopamine in some areas, and too little in the front of the brain. This study is about the second part. OCR examiners warn that students wrongly say it was about too much dopamine.

Aim

The aim was to investigate the effects of the drug dextroamphetamine (called amphetamine from here on) on the front of the brain. Amphetamine acts on dopamine and some other brain chemicals.

Researchers measured blood flow in patients with schizophrenia during the Wisconsin Card Sort Test (WCST). In this test, you sort cards by rules that you work out and change. It needs the prefrontal cortex (PFC). The PFC is the front of the brain.

The dorsolateral prefrontal cortex (DLPFC) is the upper, outer part of the PFC. More blood flow means a more active region.

In plain words, amphetamine should send more blood to the front of the brain than to the rest of the brain, during the card sort. The hypothesis is a prediction the study can test. OCR gives it as follows.

  • Hypothesis: Schizophrenic patients given dextroamphetamine will have an increased ratio of PFC to non-frontal blood flow during the WCST, compared with patients given a placebo.

Method

Design and Variables

The researchers ran a laboratory experiment. That means a controlled experiment in an artificial setting. Double-blind means neither the patients nor the raters knew which pill was given. Placebo-controlled means a dummy pill was the comparison.

Every patient had both conditions. This is repeated measures. The order of the drug and the placebo was counterbalanced, which means varied between patients.

Simply Psychology Answers
Instant answers built on 19+ years of trusted expertise.
  • Independent variable: the pill, either 0.25 mg per kg of amphetamine or a placebo.
  • Dependent variable: blood flow in many brain regions, measured by a scan during each task. The study also scored performance on the card sort.

Each patient did two tasks. One was the WCST, which needs the prefrontal cortex. The other was a simple control task that needed the same button pushing.

The control task let the researchers take away the effects of looking at a screen and pushing buttons. What was left belonged to card sorting.

Sample

  • Who: ten inpatients with chronic schizophrenia, from research wards in Washington, D.C. Chronic means long-lasting. They volunteered and gave informed consent.
  • Sex and age: four women and six men, aged 20 to 45. Eight were white and two were black.
  • Treatment: all were stable on the antipsychotic drug haloperidol for at least six weeks. It was given to help prevent the amphetamine making their psychosis worse.
  • Health: none had another illness that could affect blood flow, or drug or alcohol abuse.

Materials

  • SPECT scan: a brain scan that measures blood flow. The patient breathed in a radioactive gas, and the scanner followed where it went in the brain.
  • Wisconsin Card Sort Test (WCST): patients worked out rules for sorting cards from feedback, then changed the rule. They answered by pushing buttons on a computer.
  • Control task: patients matched the direction of bars on a screen, pushing similar buttons.

Procedure

  1. Each patient had two test days, 48 to 96 hours apart.
  2. On each day the patient swallowed either a placebo or 0.25 mg per kg of amphetamine, about 120 minutes before scanning.
  3. The patient had the head held still in the scanner and a practice run first.
  4. Blood flow was then measured during the control task and during the card sort.
  5. Two investigators who did not know which pill was given judged whether each patient had responded to the drug.
More Simply Psychology Answers
Instant answers built on 19+ years of trusted expertise.

Results

OCR credits the brain findings, so they come first. “Clearly” here means the change was unlikely to be just luck.

  • Overall blood flow: amphetamine lowered blood flow a little in every region. The drop was too small to be sure it was real.
  • On the placebo: blood flow did not clearly rise during the card sort, compared with the control task.
  • On amphetamine: activity rose clearly in the left DLPFC during the card sort.
  • Elsewhere in the left cortex: activity was suppressed, which means held down, on amphetamine.
  • Right side of the brain: activity also rose clearly in two other brain areas on amphetamine, the occipital cortex and the anterior cingulate cortex.
  • Deeper brain areas: neither condition produced a clear rise in activity in any region below the cortex.
  • Amphetamine level: how much amphetamine was in a patient’s blood was not clearly linked to blood flow.

Performance is a different kind of result. Patients got more correct answers in the card sort on amphetamine, 84 against 72. That is not a brain finding.

Conclusion

The study reached these conclusions.

  1. Amphetamine helps the cortex focus: in patients with schizophrenia, amphetamine seems to help the cortex focus its activity on a task. Overall blood flow fell slightly.
  2. A link to dopamine: the results fit the idea that low dopamine activity in the cortex is linked to hypofrontality. They suggest the problem may be partly reversible.
  3. A link to performance: the brain changes came with better card sorting.

The authors call these conclusions tentative. The sample was small, and amphetamine does not act only on dopamine. The study does not show that schizophrenia is caused by too much or too little dopamine.

Strengths

  • Double-blind and placebo-controlled: neither patients nor raters knew which pill was given. The placebo shows what happens without the drug. So expectations were less likely to explain the results.
  • Counterbalancing: varying the order of drug and placebo controls for order effects such as practice or tiredness.
  • Repeated measures: each patient was their own comparison. This removes differences between people, such as age or illness history, as an explanation.
  • A control task: it let the researchers take away the effects of doing any task. So the activity they found was specific to card sorting.
  • An objective measure: blood flow in a scan does not depend on what patients say. It avoids social desirability and demand characteristics.
  • Control of variables: the same dose per kg, the same timing, a fixed haloperidol dose and the same head position were used each time. That makes the experiment easy to repeat.
  • Real patients: the participants had schizophrenia, so the study tested the theory in the people it is about.
  • Ethical care: the patients consented, a review board approved the study, and haloperidol was used to protect them.

Limitations

  • A very small sample: only ten patients took part, and some analyses used nine.
  • Population bias: all ten were chronic inpatients aged 20 to 45 from one US hospital, mostly white, and all took haloperidol. The findings may not apply to other people with schizophrenia.
  • No healthy comparison group: everyone had schizophrenia, so the study cannot show how healthy people respond.
  • Construct validity: prefrontal function was measured with one cognitive test, which is a narrow measure of one region.
  • Ecological validity: lying in a scanner sorting cards is not an everyday situation. The controls that make it artificial are also a strength.
  • Amphetamine is not specific to dopamine: it also affects noradrenaline and serotonin, so the study cannot say which chemical caused the effect.
  • Haloperidol: the patients were also taking another drug, which may have changed how amphetamine acted in the brain.
  • Cause and effect: a drug effect does not show what causes the illness.
  • Reductionism and nature and nurture: the study explains schizophrenia by activity in one brain region.
  • One dose: a single dose was tested on one day.

A Very Small Sample

In the exam, “the sample is small” is credited as a brief criticism, for 1 mark. A developed answer earns 2 marks. It ties the point to the study. With only ten patients, the result for one brain region could depend on a few people.

The authors say their conclusions are tentative because of the modest sample size.

Cause and Effect

A drug that changes prefrontal activity does not prove what causes schizophrenia. A drug can change how the brain works without being the cause of the illness.

OCR describes the dopamine hypothesis as too much dopamine. This study treats too little dopamine in the front of the brain as the problem.

Reductionism and Nature and Nurture

OCR names the nature and nurture debate as the criticism of the biological theory of schizophrenia.

The theory focuses too much on nature, because it explains schizophrenia by brain activity. It ignores upbringing and life events.

Explaining a complex illness by one part of the brain is also reductionist. Reductionism means explaining something complex by one simple part.

Ethical Issues

The paper says the patients volunteered and gave informed consent. A review board and a radiation safety committee approved the study. Blood pressure and breathing were monitored.

  • Informed consent: the patients were hospital inpatients too ill to live independently. It may be hard to be sure how well they understood. Way of dealing: get approval from a review board, as here.
  • Protection from harm: amphetamine can make psychosis worse. Haloperidol reduced the risk and effects were mostly mild, but one patient got worse. Way of dealing: monitor patients and stop if one deteriorates.
  • Scanning for research: the patients breathed a radioactive gas and gained no treatment benefit. Way of dealing: have a radiation safety committee approve it.
  • Right to withdraw and debrief: the paper does not report either. Way of dealing: tell patients they can stop at any time, and explain the study afterwards.

Exam Questions

What OCR Asks About This Study

In the exam you get marks for these question types, all taken from OCR’s past papers on this study.

  • Multiple choice (1 mark each): the part of the brain (prefrontal cortex), the scan (SPECT), and what amphetamine did.
  • The amphetamine option: the credited option said it increased cortical activity during the card sort. That is loosely worded, because overall blood flow fell slightly. In a written answer, name the prefrontal cortex.
  • State findings about neuropsychology (3 marks): one mark for each key brain finding. Give the brain findings first. Credited: more activity, in the prefrontal cortex, and an effect on blood flow.
  • Outline one criticism of the procedure (2 marks): one mark for a basic point, two for a developed one. Credited: small sample, artificial task or setting, construct validity (one test), ethics of scans.
  • Theory questions (1 mark each): which neuron fires too often (the dopamine kind, called dopaminergic), and which is not a criticism of the biological theory (too holistic, meaning looking at the whole person).
  • 13 marks: the value of biological explanations. This study can be evidence in such an answer, with a second study or theory from a different topic.

In a 13-mark answer, Tandoc et al. cannot be the second study, because both studies are in Psychological Problems.

The three questions below are examples written in OCR’s style. They are not OCR’s own wording.

Practice Question 1: Brain Findings (3 marks)

Question [3 marks]: State three findings from Daniel et al.’s study that relate to neuropsychology.

Model answer: On amphetamine there was more activity in the prefrontal cortex during the card sort. This was clearest in the left dorsolateral prefrontal cortex. On the placebo there was no clear rise in blood flow, and overall blood flow fell slightly on amphetamine.

  • Mark scheme: 1 mark for each key brain finding. Credited: more prefrontal activity on amphetamine, a difference in blood flow, no clear change during the control task, suppression elsewhere in the left cortex.
  • Watch out: give the brain findings first. OCR’s report says few candidates kept to neuropsychology.

Practice Question 2: One Criticism (2 marks)

Question [2 marks]: Outline one criticism of the procedure used in Daniel et al.’s study.

Model answer: The study lacks construct validity. Prefrontal function was measured with only one cognitive test, the card sort. So it may not show how the whole prefrontal cortex works.

  • Mark scheme: 1 mark for a brief criticism and 2 for one developed and linked to the study. It must be about the procedure, not the findings.

Practice Question 3: Describe the Study (6 marks)

Question [6 marks]: Describe Daniel et al.’s study of the effect of amphetamine on blood flow.

Model answer: Ten patients with chronic schizophrenia took part in a laboratory experiment. It was double-blind and placebo-controlled. Each patient had two test days. They were 48 to 96 hours apart. On one day they took 0.25 mg per kg of amphetamine, and on the other a placebo.

About 120 minutes later, a SPECT scan measured blood flow while they did a control task and the Wisconsin Card Sort Test.

On amphetamine, activity rose clearly in the left dorsolateral prefrontal cortex. Activity elsewhere in the left cortex was suppressed. On the placebo there was no clear rise. Overall blood flow fell slightly.

The authors concluded that amphetamine helps the cortex focus on a task.

Later Research

Slifstein and colleagues compared 20 patients who were not taking antipsychotic drugs with 21 healthy people. After amphetamine, the patients released less dopamine in the prefrontal cortex than the healthy people did. That fits the idea of low prefrontal dopamine (Slifstein et al., 2015).

More Simply Psychology Answers
Instant answers built on 19+ years of trusted expertise.

References

Daniel, D. G., Weinberger, D. R., Jones, D. W., Zigun, J. R., Coppola, R., Handel, S., Bigelow, L. B., Goldberg, T. E., Berman, K. F., & Kleinman, J. E. (1991). The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. The Journal of Neuroscience, 11(7), 1907-1917. https://doi.org/10.1523/JNEUROSCI.11-07-01907.1991

Slifstein, M., van de Giessen, E., Van Snellenberg, J., Thompson, J. L., Narendran, R., Gil, R., Hackett, E., Girgis, R., Ojeil, N., Moore, H., D’Souza, D., Malison, R. T., Huang, Y., Lim, K., Nabulsi, N., Carson, R. E., Lieberman, J. A., & Abi-Dargham, A. (2015). Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia. JAMA Psychiatry, 72(4), 316. https://doi.org/10.1001/jamapsychiatry.2014.2414

Olivia Guy-Evans, MSc

BSc (Hons) Psychology, MSc Psychology of Education

Associate Editor for Simply Psychology

Olivia Guy-Evans is a writer and associate editor for Simply Psychology, where she contributes accessible content on psychological topics. She is also an autistic PhD student at the University of Birmingham, researching autistic camouflaging in higher education.


Saul McLeod, PhD

Chartered Psychologist (CPsychol)

BSc (Hons) Psychology, MRes, PhD, University of Manchester

Saul McLeod, PhD, is a qualified psychology teacher with over 18 years of experience in further and higher education. He has been published in peer-reviewed journals, including the Journal of Clinical Psychology.